The Scientific Advisory Board is a group of expert researchers and clinicians from the UK and Europe. They oversee and advise on Target Ovarian Cancer's research programme.
The Board provides advice on:
development of the research strategy and funding programme
which project proposals should be invited to make a full application
external reviewers for grant applications
external peer reviewer and research champion comments on full grant applications
make recommendations for research funding to our Board of Trustees
annual review of funded projects.
The Scientific Advisory Board must comply with, and declare conflicts of interest in line with, our conflicts of interest policy.
Professor Ruth Plummer, Professor of Experimental Cancer Medicine at the Northern Institute for Cancer Research, Newcastle University (Chair)
Professor Richard Edmondson, Clinical Professor in Gynaecological Oncology, Manchester University.
Dr Ros Glasspool, Consultant Medical Oncologist and Honorary Clinical Senior Lecturer, University of Glasgow
Professor Maurizio D'Incalci, Laboratory of Cancer Pharmacology, Humanitas Research Hospital, Milan
Dr Rebecca Kristeleit, Consultant Medical Oncologist, Guy's and St Thomas' NHS Foundation Trust
Professor Chris Lord, Deputy Head of Division and Leader of the Gene Function Team at The Institute of Cancer Research, London